2021 1H: Significant Progresss
- The second quarter saw the U.S. achieve significant milestones in the fight to control COVID-19, with the country reaching 50% of adults fully vaccinated in late May. Correspondingly, by mid-June both COVID cases and deaths had fallen to their lowest point since March of 2020, highlighting the impact of the country’s mass vaccination strategy.
- Private markets continued their surge during the second quarter, with transaction volume up meaningfully from both the pandemic impacted 2020 second quarter as well as 2019. Business owners concerned about potential capital gains tax increases, paired with private equity investors seeking to deploy record amounts of dry powder have worked in tandem to push activity to a frenzied pace. This activity in private markets has been paired with skyrocketing valuations in the venture capital world, most notably among late-stage start-ups.
- During the year to date, PMCF’s four Medical Technology indices have seen mixed results, though they finished the first half of 2021 tightly grouped, up between 6.4% and 8.2% on the year. This trails the benchmark S&P 500 Growth Index which climbed significantly in June and finished up 15.6%, and the Dow Jones Industrial Average, which closed up 14.2%.
Read Medical Technology M&A Pulse Q2 2021 Full Report
Medical Technology M&A Pulse – Q4 2025
M&A activity in the Medical Technology sector stayed on par with the previous two quarters, with 105 announced transactions. Volume is significantly lower than the same quarter last year, with 135 deals in Q4 2024.
Medical Technology M&A Pulse – Q3 2025
M&A activity in the Medical Technology sector remained subdued in Q3 2025 at 102 announced transactions, significantly below the 165 deals recorded in Q3 2024.
Medical Technology M&A Pulse – Q2 2025
M&A activity in the Medical Technology sector remained subdued in Q2 2025, with 104 announced transactions, a decline from the 128 deals recorded in Q2 2024.
Medical Technology M&A Pulse – Q1 2025
MEDICAL TECHNOLOGY M&A MARKET DYNAMICS M&A activity in the Medical Technology sector was relatively soft in Q1 2025, with 118 announced transactions, falling short of the 135 deals recorded in Q1 2024. To keep pace with the relatively stable deal volumes seen over the past three years on a yearly basis, the market will need…
Medical Technology M&A Pulse – Q4 2024
MedTech M&A deal volume in 2024 remained consistent with 2023 levels despite headwinds from rising input costs and regulatory shifts over the past year.